![Breca Tracy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Breca Tracy
Corporate Officer/Principal at Heparinex LLC
Breca Tracy active positions
Companies | Position | Start | End |
---|---|---|---|
Heparinex LLC
![]() Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Corporate Officer/Principal | - | - |
Career history of Breca Tracy
Former positions of Breca Tracy
Companies | Position | Start | End |
---|---|---|---|
Emergent Technologies, Inc.
![]() Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Private Equity Analyst | 23/04/2009 | 30/09/2017 |
Training of Breca Tracy
Stephens College | Undergraduate Degree |
University of Oklahoma | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Private Equity Analyst | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Emergent Technologies, Inc.
![]() Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Finance |
Heparinex LLC
![]() Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
- Stock Market
- Insiders
- Breca Tracy
- Experience